|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-8-21
|
|
pubmed:abstractText |
To investigate the relationship between activities of daily living (ADL) impairment and Alzheimer's disease (AD) severity in mild to moderately severe AD patients receiving the cholinesterase (ChE) inhibitor rivastigmine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0278-5846
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
713-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12188104-Activities of Daily Living,
pubmed-meshheading:12188104-Adult,
pubmed-meshheading:12188104-Aged,
pubmed-meshheading:12188104-Aged, 80 and over,
pubmed-meshheading:12188104-Alzheimer Disease,
pubmed-meshheading:12188104-Analysis of Variance,
pubmed-meshheading:12188104-Carbamates,
pubmed-meshheading:12188104-Double-Blind Method,
pubmed-meshheading:12188104-Humans,
pubmed-meshheading:12188104-Middle Aged,
pubmed-meshheading:12188104-Phenylcarbamates
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease.
|
|
pubmed:affiliation |
Brain Imaging Center, Department of Psychiatry and Human Behavior, University of California, Irvine 92697, USA. sgpotkin@uci.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
